Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you entertained over the weekend.

A mid-stage trial of 4D Molecular Therapeutics gene therapy for eye disease age-related macular degeneration (AMD) 4D-150 has shown promising signs of efficacy, plus a reduced need for injections ...

It's an intravenously administered follow-up to zelquistinel – Gate's lead programme – which is being developed as a once weekly oral treatment for MDD and is in a phase 2 trial. ASAT is a ...